Paper34412058
Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders.
Hill SF and 1 other. Dev Neurosci, 2021. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders. Papers, record 34412058. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34412058
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscular Atrophy, Spinal | Major topic |
| Neurodevelopmental Disorders | Major topic |
| Animals | |
| Disease Models, Animal | |
| Humans | |
| Mice | |
| NAV1.1 Voltage-Gated Sodium Channel | |
| Oligonucleotides, Antisense | |
| RNA Splicing |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 NS034509 | NINDS NIH HHS | United States | R01NS034509 | PubMed and NIH |
Source NIH RePORTER
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31506303 | Nusinersen for Type 1 Spinal Muscular Atrophy: A Father's Perspective. | Pediatrics | 2019 | https://conductscience.org/library/papers/31506303 | PubMed |
| 2 | 17537961 | Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. | J Neurosci | 2007 | https://conductscience.org/library/papers/17537961 | PubMed |
| 3 | 8390996 | Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8390996 | PubMed |
| 4 | 33531663 | Sodium channelopathies in neurodevelopmental disorders. | Nat Rev Neurosci | 2021 | https://conductscience.org/library/papers/33531663 | PubMed |
| 5 | 24784568 | Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24784568 | PubMed |
| 6 | 25568300 | The phenotypic spectrum of SCN8A encephalopathy. | Neurology | 2015 | https://conductscience.org/library/papers/25568300 | PubMed |
| 7 | 33307321 | Children and young adults with spinal muscular atrophy treated with nusinersen. | Eur J Paediatr Neurol | 2021 | https://conductscience.org/library/papers/33307321 | PubMed |
| 8 | 28192393 | Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28192393 | PubMed |
| 9 | 20624852 | Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. | Genes Dev | 2010 | https://conductscience.org/library/papers/20624852 | PubMed |
| 10 | 31943325 | Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome. | Ann Neurol | 2020 | https://conductscience.org/library/papers/31943325 | PubMed |
| 11 | 9259265 | The survival motor neuron protein in spinal muscular atrophy. | Hum Mol Genet | 1997 | https://conductscience.org/library/papers/9259265 | PubMed |
| 12 | 9077498 | A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. | J Neurol Sci | 1997 | https://conductscience.org/library/papers/9077498 | PubMed |
| 13 | 31036929 | Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31036929 | PubMed |
| 14 | 28244990 | The chemical evolution of oligonucleotide therapies of clinical utility. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28244990 | PubMed |
| 15 | 9880552 | Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. | J Biol Chem | 1999 | https://conductscience.org/library/papers/9880552 | PubMed |
| 16 | 21971427 | Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin. | Mol Ther | 2011 | https://conductscience.org/library/papers/21971427 | PubMed |
| 17 | 27939059 | Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. | Lancet | 2016 | https://conductscience.org/library/papers/27939059 | PubMed |
| 18 | 7813012 | Identification and characterization of a spinal muscular atrophy-determining gene. | Cell | 1995 | https://conductscience.org/library/papers/7813012 | PubMed |
| 19 | 29091557 | Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29091557 | PubMed |
| 20 | 21482919 | Spinal muscular atrophy: a timely review. | Arch Neurol | 2011 | https://conductscience.org/library/papers/21482919 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42742464 | Neural Stem Cell-Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42742464 | PubMed |
| 42737622 | RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737622 | PubMed |
| 42441133 | HNF1B-related disease: developmental origins, molecular mechanisms, and multisystem clinical challenges. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42441133 | PubMed |
| 42095821 | [Spinal muscular atrophy: Clinical and genetic aspects, and therapeutic alternatives]. | Rev Med Inst Mex Seguro Soc | 2026 | https://conductscience.org/library/papers/42095821 | PubMed |
| 42071079 | Bridging development and disease: the potential of LncRNAs as biomarkers and therapeutics in pediatric neurological disorders. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42071079 | PubMed |
| 41678398 | Alternative splicing-triggered mRNA decay informs splice-switching targets for neurodevelopmental disorders. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41678398 | PubMed |
| 41515912 | From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41515912 | PubMed |
| 41509361 | Rescuing Neurodevelopmental Deficits in AMPA Receptor Gain-of-Function Mutant. | bioRxiv | 2025 | https://conductscience.org/library/papers/41509361 | PubMed |
| 41465141 | Artificial Intelligence-Driven Design of Antisense Oligonucleotides for Precision Medicine in Neuromuscular Disorders. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41465141 | PubMed |
| 41323796 | SCAD: A modular platform for efficient delivery of duplex RNA to the CNS and beyond. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41323796 | PubMed |
| 41153385 | RNA-Targeting Techniques: A Comparative Analysis of Modern Approaches for RNA Manipulation in Cancer Research and Therapeutics. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41153385 | PubMed |
| 40808385 | Voltage-gated sodium channels in the nervous system: Molecular physiology to therapeutic interventions. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40808385 | PubMed |
| 40534528 | RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System. | Biomol Ther (Seoul) | 2025 | https://conductscience.org/library/papers/40534528 | PubMed |
| 40523177 | Single Antisense Oligonucleotides Correct Diverse Splicing Mutations in Hotspot Exons. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40523177 | PubMed |
| 40400017 | Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one-third of neurodevelopmental disorders. | Genome Med | 2025 | https://conductscience.org/library/papers/40400017 | PubMed |
| 40295879 | Interictal network dysfunction and cognitive impairment in epilepsy. | Nat Rev Neurosci | 2025 | https://conductscience.org/library/papers/40295879 | PubMed |
| 40217359 | Genetic mechanisms in generalized epilepsies. | Acta Epileptol | 2023 | https://conductscience.org/library/papers/40217359 | PubMed |
| 40160416 | Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders. | iScience | 2025 | https://conductscience.org/library/papers/40160416 | PubMed |
| 39991982 | Natural History of NAA15 -Related Neurodevelopmental Disorder Through Adolescence. | Am J Med Genet A | 2025 | https://conductscience.org/library/papers/39991982 | PubMed |
| 39989508 | Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies. | Ther Adv Rare Dis | 2025 | https://conductscience.org/library/papers/39989508 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MFSD8 | 256471 | PubTator's text mining | https://conductscience.org/library/genes/256471 | NCBI Gene |
| RNASEH1 | 246243 | PubTator's text mining | https://conductscience.org/library/genes/246243 | NCBI Gene |
| SCN1A | 6323 | PubTator's text mining | https://conductscience.org/library/genes/6323 | NCBI Gene |
| SCN8A | 6334 | PubTator's text mining | https://conductscience.org/library/genes/6334 | NCBI Gene |
| SMN1 | 6606 | PubTator's text mining | https://conductscience.org/library/genes/6606 | NCBI Gene |
| SMN2 | 6607 | PubTator's text mining | https://conductscience.org/library/genes/6607 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34412058
GET https://conductscience.org/api/papers/v1/34412058/references?page=2